Note: This study found no significant biological effects under its experimental conditions. We include all studies for scientific completeness.
No Changes in Cerebral Microcirculatory Parameters in Rat During Local Cortex Exposure to Microwaves
No Effects Found
Masuda H, Hirota S, Ushiyama A, Hirata A, Arima T, Watanabe H, Wake K, Watanabe S, Taki M, Nagai A, Ohkubo C · 2015
This cardiovascular medication study was incorrectly categorized as EMF research, showing no electromagnetic effects because none were tested.
Plain English Summary
Summary written for general audiences
This study appears to be misclassified in the EMF database. The research examined blood pressure medications (benidipine combined with different drugs) in 2,983 patients over 18 months. The study found no electromagnetic field effects because it wasn't testing EMF exposure at all - it was purely a cardiovascular medication trial.
Cite This Study
Masuda H, Hirota S, Ushiyama A, Hirata A, Arima T, Watanabe H, Wake K, Watanabe S, Taki M, Nagai A, Ohkubo C (2015). No Changes in Cerebral Microcirculatory Parameters in Rat During Local Cortex Exposure to Microwaves.
Show BibTeX
@article{masuda_h_hirota_s_ushiyama_a_hirata_a_arima_t_watanabe_h_wake_k_watanabe_s_taki_m_nagai_a_ohkubo_c_ce3373,
author = {Masuda H and Hirota S and Ushiyama A and Hirata A and Arima T and Watanabe H and Wake K and Watanabe S and Taki M and Nagai A and Ohkubo C},
title = {No Changes in Cerebral Microcirculatory Parameters in Rat During Local Cortex Exposure to Microwaves},
year = {2015},
doi = {10.1038/hr.2015.104},
}Quick Questions About This Study
This appears to be a database categorization error. The study examined combinations of cardiovascular drugs (benidipine with ARB, beta-blockers, or thiazide) and their effects on blood pressure variability, with no electromagnetic field exposure involved.
This study didn't examine EMF sensitivity at all. It focused solely on how different blood pressure medication combinations (benidipine-thiazide vs benidipine-beta-blocker vs benidipine-ARB) affected visit-to-visit blood pressure variability in cardiovascular patients.
This study provides no information about EMF protection. It was a cardiovascular medication trial comparing the effectiveness of different drug combinations in reducing blood pressure variability, completely unrelated to electromagnetic field exposure.
While blood pressure variability is an important health metric that could theoretically be studied in EMF research, this particular study only examined pharmaceutical interventions and provides no EMF-related data or insights.
This study offers no guidance for EMF-sensitive individuals. It was a standard pharmaceutical trial comparing medication effectiveness for blood pressure control, with no consideration of electromagnetic field exposure or sensitivity.